Severe Pneumocystis jirovecii Pneumonia as the Sentinel Presentation of BENTA Disease: Case Report of a 3-Month-old Infant.

Pediatr Infect Dis JMay 18, 2026 (epub)

Andrés Felipe Rubio-Duarte, María Paula Garcés-Rodríguez, Alexandra Hurtado-Ortiz et al.

✦ AI-curated · Sources linked

Case in brief

A 3-month-old infant with a history of acute respiratory distress syndrome and recurrent infections that did not respond to antibiotics had persistent interstitial lung opacities. Immunologic evaluation showed T-cell lymphopenia and a CARD11 mutation, while respiratory polymerase chain reaction confirmed Pneumocystis jirovecii pneumonia. The infection was treated with trimethoprim-sulfamethoxazole and intravenous immunoglobulin, and the infant recovered.

What made this case unusual

P. jirovecii pneumonia was the sentinel presentation of BENTA disease in this infant, whose recurrent infections and persistent lung opacities prompted recognition of the underlying immunodeficiency.

Diagnostic / clinical pearl

In an HIV-negative infant with persistent interstitial opacities and recurrent infections unresponsive to antibiotics, consider an underlying immunodeficiency and investigate for P. jirovecii.

Source

Published in Pediatr Infect Dis J. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.